![Astellas Pharma / Pharmaceutical industry in India / Micafungin / Pharmaceutical industry / Tamsulosin / Regadenoson / Chemistry / Pharmaceutical sciences / Pharmacology Astellas Pharma / Pharmaceutical industry in India / Micafungin / Pharmaceutical industry / Tamsulosin / Regadenoson / Chemistry / Pharmaceutical sciences / Pharmacology](https://www.pdfsearch.io/img/66855a8d448560d8fc2eaf57f6ef7a4a.jpg)
| Document Date: 2010-10-25 00:58:50 Open Document File Size: 2,27 MBShare Result on Facebook
Company Profile Profile Astellas Pharma Inc. / Astellas Group / Astellas Pharma Inc. / / Continent Asia / Europe / Americas / / Country Japan / United States / / Currency USD / EUR / / Event Dividend Issuance / Reorganization / / IndustryTerm in-license products / existing and new products / mainstay products / protein drug technologies / growth products / treatment for the functional symptoms / research-oriented global pharmaceutical / pharmaceuticals / overactive bladder technologies / communications slogan / manufacturing costs / ethical pharmaceutical products / main growth products / well-balanced global business network / growth product / treatment for migraine / ethical pharmaceutical / pharmaceutical products / business operations / pharmaceutical / well-balanced global sales network / business infrastructure / sales network / prostate cancer treatment / focused on establishing a solid global business infrastructure / / Person Masafumi Nogimori / / Position leader / Major / global category leader / President & CEO / / Product Vesicare / Eligard / Prograf / Harnal / / Technology drug discovery / transplantation / protein drug technologies / overactive bladder technologies / /
SocialTag |